Log in
Enquire now
‌

US Patent 10059690 Inhibitors of cyclin-dependent kinase 7 (CDK7)

Patent 10059690 was granted and assigned to Syros Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Syros Pharmaceuticals
Syros Pharmaceuticals
0
Date Filed
October 31, 2017
0
Date of Patent
August 28, 2018
0
Patent Applicant
Syros Pharmaceuticals
Syros Pharmaceuticals
0
Patent Application Number
15799661
0
Patent Citations Received
‌
US Patent 10519135 Inhibitors of cyclin-dependent kinase 7 (CDK7)
0
‌
US Patent 12084453 Bicyclic amines as CDK12 inhibitors
0
‌
US Patent 12065445 CDK2 inhibitors and methods of using the same
0
‌
US Patent 10766884 Cyclin dependent kinase inhibitors
Patent Inventor Names
Dana K. Winter
0
Amy Ripka
0
Anzhelika Kabro
0
Stephane Ciblat
0
Stephanie Roy
0
Tom Miller
0
Dansu Li
0
Darby Schmidt
0
Jason J. Marineau
0
Kevin Sprott
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10059690
0
Patent Primary Examiner
‌
Jeffrey H Murray
0

Find more entities like US Patent 10059690 Inhibitors of cyclin-dependent kinase 7 (CDK7)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.